Highlights and Quick Summary
- R&D Expenses for the quarter ending September 30, 2022 was $85.3 Million (a 14.39% increase compared to previous quarter)
- Year-over-year quarterly R&D Expenses decreased by -11.88%
- Annual R&D Expenses for 2021 was $387 Million (a 275.16% increase from previous year)
- Annual R&D Expenses for 2020 was $103 Million (a 88.91% increase from previous year)
- Annual R&D Expenses for 2019 was $54.6 Million (a 61.25% increase from previous year)
- Twelve month R&D Expenses ending September 30, 2022 was $322 Million (a 10.52% increase compared to previous quarter)
- Twelve month trailing R&D Expenses decreased by -16.81% year-over-year
Trailing R&D Expenses for the last four month:
| 30 Sep '22 | 30 Jun '22 | 31 Mar '22 | 31 Dec '21 |
|---|---|---|---|
| $322 Million | $291 Million | $262 Million | $387 Million |
Visit stockrow.com/BEAM
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical R&D Expenses of Beam Therapeutics Inc.
Most recent R&D Expensesof BEAM including historical data for past 10 years.Interactive Chart of R&D Expenses of Beam Therapeutics Inc.
Beam Therapeutics Inc. R&D Expenses for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2022 | – | $85.29 | $74.56 | $65.41 | – |
| 2021 | $96.78 | $54.62 | $45.58 | $190.11 | $387.09 |
| 2020 | $32.45 | $29.83 | $19.35 | $21.55 | $103.18 |
| 2019 | $20.22 | $12.54 | $12.68 | $9.18 | $54.62 |
| 2018 | – | – | – | – | $33.87 |
| 2017 | – | – | – | – | $5.86 |
Business Profile of Beam Therapeutics Inc.
Sector: Healthcare
Industry: Biotechnology